MediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company's product, NexoBrid, is indicated for the removal of dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns. The Company sells NexoBrid in Europe and Israel. NexoBrid is a topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. Its product, EscharEx, is a topical biological drug, which is being developed for debridement of chronic and other hard-to-heal wounds. NexoBrid and EscharEx are based on its proteolytic enzyme technology. The Company is also developing an injectable product based on its proteolytic enzyme technology for connective tissue pathologies and indications.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Symbol: NASDAQ:MDWD
- CUSIP: N/A
- Web: www.mediwound.com
- Market Cap: $150.77 million
- Outstanding Shares: 21,930,000
- 50 Day Moving Avg: $6.42
- 200 Day Moving Avg: $5.82
- 52 Week Range: $4.25 - $8.58
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -10.11
- P/E Growth: -0.080
- Annual Revenue: $1.84 million
- Price / Sales: 81.94
- Book Value: $0.17 per share
- Price / Book: 39.97
- EBIDTA: ($19,190,000.00)
- Net Margins: -1,776.06%
- Return on Equity: -148.23%
- Return on Assets: -53.44%
- Current Ratio: 7.55%
- Quick Ratio: 7.34%
- Average Volume: 38,739 shs.
- Beta: 0.03
- Short Ratio: 12.39
Frequently Asked Questions for Mediwound Ltd (NASDAQ:MDWD)
What is Mediwound Ltd's stock symbol?
Mediwound Ltd trades on the NASDAQ under the ticker symbol "MDWD."
How were Mediwound Ltd's earnings last quarter?
Mediwound Ltd (NASDAQ:MDWD) posted its quarterly earnings results on Monday, May, 8th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.17) by $0.03. The business earned $0.54 million during the quarter, compared to analyst estimates of $0.56 million. Mediwound Ltd had a negative return on equity of 148.23% and a negative net margin of 1,776.06%. The business's revenue for the quarter was up 112.6% on a year-over-year basis. During the same period last year, the company earned ($0.17) EPS. View Mediwound Ltd's Earnings History.
Where is Mediwound Ltd's stock going? Where will Mediwound Ltd's stock price be in 2017?
4 brokers have issued 12 month price objectives for Mediwound Ltd's shares. Their forecasts range from $10.00 to $14.00. On average, they anticipate Mediwound Ltd's share price to reach $12.00 in the next twelve months. View Analyst Ratings for Mediwound Ltd.
Who are some of Mediwound Ltd's key competitors?
Some companies that are related to Mediwound Ltd include Ocular Therapeutix (OCUL), XBiotech (XBIT), Novavax (NVAX), Ignyta (RXDX), Veracyte (VCYT), SIGA Technologies (SIGA), Dynavax Technologies (DVAX), Nabriva Therapeutics AG - (NBRV), Compugen (CGEN), Minerva Neurosciences (NERV), Ardelyx (ARDX), Sinovac Biotech (SVA), Kamada Ltd (KMDA), Akebia Therapeutics (AKBA), Idera Pharmaceuticals (IDRA), Curis (CRIS), Anavex Life Sciences Corp. (AVXL) and Abeona Therapeutics (ABEO).
Who owns Mediwound Ltd stock?
Mediwound Ltd's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Wellington Management Group LLP (9.84%), Broadfin Capital LLC (2.89%), Massachusetts Financial Services Co. MA (2.25%), California Public Employees Retirement System (0.91%), Morgan Stanley (0.65%) and United Services Automobile Association (0.56%). View Institutional Ownership Trends for Mediwound Ltd.
Who sold Mediwound Ltd stock? Who is selling Mediwound Ltd stock?
Mediwound Ltd's stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Oppenheimer & Co. Inc., United Services Automobile Association and Massachusetts Financial Services Co. MA. View Insider Buying and Selling for Mediwound Ltd.
Who bought Mediwound Ltd stock? Who is buying Mediwound Ltd stock?
Mediwound Ltd's stock was bought by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Wells Fargo & Company MN and Renaissance Technologies LLC. View Insider Buying and Selling for Mediwound Ltd.
How do I buy Mediwound Ltd stock?
Shares of Mediwound Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Mediwound Ltd stock cost?
One share of Mediwound Ltd stock can currently be purchased for approximately $6.88.
Earnings History for Mediwound Ltd (NASDAQ:MDWD)Earnings History by Quarter for Mediwound Ltd (NASDAQ:MDWD)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/8/2017||3/31/2017||($0.17)||($0.20)||$0.56 million||$0.54 million||View||Listen|
|2/21/2017||12/31/2016||($0.25)||($0.09)||$0.73 million||$0.43 million||View||Listen|
|11/14/2016||Q316||($0.26)||($0.26)||$0.61 million||$0.52 million||View||N/A|
|7/28/2016||Q216||($0.23)||($0.34)||$0.45 million||$3.36 million||View||Listen|
|4/21/2016||Q116||($0.24)||($0.17)||$0.28 million||$0.25 million||View||Listen|
|1/25/2016||Q415||($0.23)||($0.36)||$0.40 million||$0.27 million||View||Listen|
|10/27/2015||Q315||($0.31)||($0.17)||$0.47 million||$334.00 million||View||Listen|
|8/3/2015||Q215||($0.26)||($0.19)||$0.22 million||$0.17 million||View||Listen|
|5/4/2015||Q1 2015||($0.30)||($0.28)||$0.18 million||$0.07 million||View||Listen|
|2/12/2015||Q4||($0.26)||($0.33)||$0.10 million||$0.12 million||View||Listen|
|11/5/2014||Q3||($0.25)||($0.24)||$0.31 million||$0.05 million||View||Listen|
|7/31/2014||Q2||($0.15)||($0.28)||$0.19 million||$0.89 million||View||Listen|
|5/2/2014||Q1 2014||($0.11)||($0.05)||$0.05 million||View||N/A|
Earnings Estimates for Mediwound Ltd (NASDAQ:MDWD)
2017 EPS Consensus Estimate: ($0.72)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Mediwound Ltd (NASDAQ:MDWD)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Mediwound Ltd (NASDAQ:MDWD)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Mediwound Ltd (NASDAQ:MDWD)
Latest Headlines for Mediwound Ltd (NASDAQ:MDWD)
Mediwound Ltd (MDWD) Chart for Tuesday, May, 23, 2017